Allarity closes $20M financing for stenoparib advancement

1 week ago 12

TipRanks

Sat, March 7, 2026 astatine 7:19 AM CST 1 min read

Allarity (ALLR) Therapeutics closed a $20 cardinal non-convertible indebtedness financing with Streeterville Capital. The transaction is structured arsenic a enactment acquisition statement pursuant to which the Company issued 2 non-convertible promissory notes: a promissory enactment successful the archetypal main magnitude of $10,930,000 and a secured promissory enactment successful the archetypal main magnitude of $10,000,000, unneurotic providing astir $20 cardinal successful nett proceeds to the Company. The financing is expected to widen the Company’s currency runway into the summertime of 2028. The Company intends to usage the proceeds chiefly to enactment cardinal initiatives designed to accelerate the beforehand of stenoparib toward pivotal development, FDA support and commercialization.

Unlock hedge fund-level information and almighty investing tools for smarter, sharper decisions
Stay up of the marketplace with the latest quality and investigation and maximize your portfolio's potential

Published archetypal connected TheFly – the eventual root for real-time, market-moving breaking fiscal news. Try Now>>

See the apical stocks recommended by analysts >>

Read More connected ALLR:

Disclaimer & DisclosureReport an Issue

Allarity doses archetypal patients successful Phase 2 proceedings of SCLC
Allarity denote enrollment unfastened for Phase 2 proceedings of stenoparib, temozolomide
Allarity Therapeutics Secures Flexible Equity Financing Facility

Read Entire Article